Over the last decade, we have aggressively pursued our vision for inorganic growth and acquired facilities for API as well as intermediates. Our next vision is for all globally approved manufacturing units in the state of Madhya Pradesh to serve formulations like hormones, renal injectables, and oncology as well as beta-lactams.
These will give us leverage to expand and serve customers who look for low-cost manufacturing businesses and help us by enhancing our profitability by supplying to global markets. Our success has given us the confidence, respect, and credibility. We continue to acquire and develop winning strengths and capabilities in our drive towards becoming a research-driven Indian pharmaceutical company operating on a global scale.
Mr. Tapan H. Sanghvi
CEO / Director